Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control
Dion Zappe1, Cheraz Cherif Papst2, Philippe Ferber3, On behalf of the PROMPT investigators1Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 2Novartis Pharma Ag, Basel, Switzerland; 3Roche Pharmaceuticals, Basel, SwitzerlandObjective: Delays in achieving blood pressure (BP) control may in...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-10-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/randomized-study-to-compare-valsartan-plusmn-hctz-versus-amlodipine-pl-a3661 |